ProCE Banner Activity

Targeting the Lymphocyte-Activation Gene-3 (LAG-3) Immune Checkpoint in Patients With Cancer: Awareness and Confidence Among Oncology Healthcare Professionals

PDF

This poster, presented at the Society of Immunotherapy for Cancer Annual Meeting 2022, illustrates gaps in awareness of and confidence in using LAG-3 therapies for cancer among healthcare professionals.

Released: November 10, 2022

Expiration: November 09, 2023

No longer available for credit.

Share

Additional Information

Contact:

Marie Becker,

PhDScientific Director,

Oncology

Clinical Care Options, LLC

Telephone: 850-228-4168

mbecker@clinicaloptions.com